Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Retinal neovascularisation: Which Medications Are Safest? (22 Drugs Compared)

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

22 medications are used for Retinal neovascularisation, with 448 combined adverse event reports. The most reported drugs for Retinal neovascularisation are RANIBIZUMAB and FARICIMAB\FARICIMAB-SVOA.

448
Total Reports
22
Drugs Used

All Medications for Retinal neovascularisation Ranked by Safety Reports

Drug Brand Reports Deaths (all) Hosp. (all) Death Rate
RANIBIZUMAB CIMERLI 166 2,651 2,265 17.3%
FARICIMAB\FARICIMAB-SVOA - 149 97 79 2.9%
AFLIBERCEPT EYLEA 63 8,527 3,193 31.7%
BEVACIZUMAB JOBEVNE 53 17,498 23,114 22.4%
FARICIMAB-SVOA - 18 175 169 9.2%
BROLUCIZUMAB-DBLL - 7 198 170 7.1%

View all 22 drugs →

Most Reported Drugs for Retinal neovascularisation

#1 most reported
#2 most reported
#3 most reported